| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Jean Jacques Bienaime is Director at BMRN and has filed Form 4s across 6 companies. From September 2015 to August 2026, the filings on record show 21 open-market purchases and 123 sales. Jean Jacques Bienaime's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $31.2M at current prices.
Historically, Jean Jacques Bienaime's trades have earned a middling insider score of 68/100 across 67 rated trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +8.5%.
The biggest single holding is BMRN (~$26.4M) as Director. The BMRN filings lean toward selling, a net 2,115,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 4,000 | $81.97 | $327,888.40 | -1.2% | |
| May 8, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 4,000 | $82.16 | $328,624.80 | -1.2% | |
| Apr 26, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 3,000 | $82.88 | $248,640.40 | -0.9% | |
| Apr 12, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 4,000 | $89.12 | $356,480.00 | -1.2% | |
| Apr 8, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 3,000 | $91.87 | $275,597.62 | -0.9% | |
| Apr 5, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 3,000 | $93.37 | $280,113.60 | -0.9% | |
| Mar 25, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 4,000 | $87.86 | $351,440.00 | -1.2% | |
| Mar 15, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 4,000 | $94.40 | $377,600.00 | -1.2% | |
| Mar 13, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 3,000 | $93.42 | $280,253.40 | -0.9% | |
| Mar 12, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 9,000 | $90.06 | $810,549.90 | -2.7% |